Data from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis Article Swipe

View

Laetitia Devy , Lili Huang , Laurent Naa , Niranjan Yanamandra , Henk Pieters , Nicolas Frans , Edward Yi Chang , Qingfeng Tao , Marc Vanhove , Annabelle Lejeune , Reinoud van Gool , Daniel J. Sexton , Guannan Kuang , Douglas Rank , Shannon Hogan , Csaba Pazmany , Yu Lu , Sonia Schoonbroodt , Andrew E. Nixon , Robert C. Ladner , Rene Hoet , Paula Henderikx , Chris TenHoor , Shafaat A. Rabbani , Maria Luisa Valentino , Clive R. Wood , Daniel T. Dransfield ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/0008-5472.c.6499896

Inhibition of specific matrix metalloproteinases (MMP) is an attractive noncytotoxic approach to cancer therapy. MMP-14, a membrane-bound zinc endopeptidase, has been proposed to play a central role in tumor growth, invasion, and neovascularization. Besides cleaving matrix proteins, MMP-14 activates proMMP-2 leading to an amplification of pericellular proteolytic activity. To examine the contribution of MMP-14 to tumor growth and angiogenesis, we used DX-2400, a highly selective fully human MMP-14 inhibitory antibody discovered using phage display technology. DX-2400 blocked proMMP-2 processing on tumor and endothelial cells, inhibited angiogenesis, and slowed tumor progression and formation of metastatic lesions. The combination of potency, selectivity, and robust in vivo activity shows the potential of a selective MMP-14 inhibitor for the treatment of solid tumors. [Cancer Res 2009;69(4):1517–26]

Related Topics

Concepts

Matrix metalloproteinase Angiogenesis Matrix metalloproteinase inhibitor Cancer research Metalloproteinase Chemistry Angiogenesis inhibitor Biology Biochemistry

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/0008-5472.c.6499896
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4392684154

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4392684154

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/0008-5472.c.6499896

Digital Object Identifier
Title: Data from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-30

Full publication date if available
Authors: Laetitia Devy, Lili Huang, Laurent Naa, Niranjan Yanamandra, Henk Pieters, Nicolas Frans, Edward Yi Chang, Qingfeng Tao, Marc Vanhove, Annabelle Lejeune, Reinoud van Gool, Daniel J. Sexton, Guannan Kuang, Douglas Rank, Shannon Hogan, Csaba Pazmany, Yu Lu, Sonia Schoonbroodt, Andrew E. Nixon, Robert C. Ladner, Rene Hoet, Paula Henderikx, Chris TenHoor, Shafaat A. Rabbani, Maria Luisa Valentino, Clive R. Wood, Daniel T. Dransfield

List of authors in order
Landing page: https://doi.org/10.1158/0008-5472.c.6499896

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/0008-5472.c.6499896

Direct OA link when available
Concepts: Matrix metalloproteinase, Angiogenesis, Matrix metalloproteinase inhibitor, Cancer research, Metalloproteinase, Chemistry, Angiogenesis inhibitor, Biology, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4392684154
doi	https://doi.org/10.1158/0008-5472.c.6499896
ids.doi	https://doi.org/10.1158/0008-5472.c.6499896
ids.openalex	https://openalex.org/W4392684154
fwci
type	preprint
title	Data from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10620
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.970300018787384
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1306
topics[0].subfield.display_name	Cancer Research
topics[0].display_name	Protease and Inhibitor Mechanisms
topics[1].id	https://openalex.org/T11736
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9467999935150146
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	Histone Deacetylase Inhibitors Research
topics[2].id	https://openalex.org/T12505
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9366999864578247
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2730
topics[2].subfield.display_name	Oncology
topics[2].display_name	Peptidase Inhibition and Analysis
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C109523444
concepts[0].level	2
concepts[0].score	0.8295873403549194
concepts[0].wikidata	https://www.wikidata.org/wiki/Q424216
concepts[0].display_name	Matrix metalloproteinase
concepts[1].id	https://openalex.org/C2780394083
concepts[1].level	2
concepts[1].score	0.7558853626251221
concepts[1].wikidata	https://www.wikidata.org/wiki/Q539568
concepts[1].display_name	Angiogenesis
concepts[2].id	https://openalex.org/C2775958869
concepts[2].level	3
concepts[2].score	0.7166481018066406
concepts[2].wikidata	https://www.wikidata.org/wiki/Q16966320
concepts[2].display_name	Matrix metalloproteinase inhibitor
concepts[3].id	https://openalex.org/C502942594
concepts[3].level	1
concepts[3].score	0.5437309741973877
concepts[3].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[3].display_name	Cancer research
concepts[4].id	https://openalex.org/C55728118
concepts[4].level	3
concepts[4].score	0.4703937768936157
concepts[4].wikidata	https://www.wikidata.org/wiki/Q425402
concepts[4].display_name	Metalloproteinase
concepts[5].id	https://openalex.org/C185592680
concepts[5].level	0
concepts[5].score	0.46963974833488464
concepts[5].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[5].display_name	Chemistry
concepts[6].id	https://openalex.org/C2776056115
concepts[6].level	3
concepts[6].score	0.43934938311576843
concepts[6].wikidata	https://www.wikidata.org/wiki/Q574834
concepts[6].display_name	Angiogenesis inhibitor
concepts[7].id	https://openalex.org/C86803240
concepts[7].level	0
concepts[7].score	0.29088133573532104
concepts[7].wikidata	https://www.wikidata.org/wiki/Q420
concepts[7].display_name	Biology
concepts[8].id	https://openalex.org/C55493867
concepts[8].level	1
concepts[8].score	0.2519705891609192
concepts[8].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[8].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/matrix-metalloproteinase
keywords[0].score	0.8295873403549194
keywords[0].display_name	Matrix metalloproteinase
keywords[1].id	https://openalex.org/keywords/angiogenesis
keywords[1].score	0.7558853626251221
keywords[1].display_name	Angiogenesis
keywords[2].id	https://openalex.org/keywords/matrix-metalloproteinase-inhibitor
keywords[2].score	0.7166481018066406
keywords[2].display_name	Matrix metalloproteinase inhibitor
keywords[3].id	https://openalex.org/keywords/cancer-research
keywords[3].score	0.5437309741973877
keywords[3].display_name	Cancer research
keywords[4].id	https://openalex.org/keywords/metalloproteinase
keywords[4].score	0.4703937768936157
keywords[4].display_name	Metalloproteinase
keywords[5].id	https://openalex.org/keywords/chemistry
keywords[5].score	0.46963974833488464
keywords[5].display_name	Chemistry
keywords[6].id	https://openalex.org/keywords/angiogenesis-inhibitor
keywords[6].score	0.43934938311576843
keywords[6].display_name	Angiogenesis inhibitor
keywords[7].id	https://openalex.org/keywords/biology
keywords[7].score	0.29088133573532104
keywords[7].display_name	Biology
keywords[8].id	https://openalex.org/keywords/biochemistry
keywords[8].score	0.2519705891609192
keywords[8].display_name	Biochemistry
language	en
locations[0].id	doi:10.1158/0008-5472.c.6499896
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/0008-5472.c.6499896
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5030051484
authorships[0].author.orcid
authorships[0].author.display_name	Laetitia Devy
authorships[0].author_position	first
authorships[0].raw_author_name	Laetitia Devy
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5100729413
authorships[1].author.orcid	https://orcid.org/0000-0002-4486-3532
authorships[1].author.display_name	Lili Huang
authorships[1].author_position	middle
authorships[1].raw_author_name	Lili Huang
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5074835230
authorships[2].author.orcid
authorships[2].author.display_name	Laurent Naa
authorships[2].author_position	middle
authorships[2].raw_author_name	Laurent Naa
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5059937355
authorships[3].author.orcid
authorships[3].author.display_name	Niranjan Yanamandra
authorships[3].author_position	middle
authorships[3].raw_author_name	Niranjan Yanamandra
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5054549500
authorships[4].author.orcid
authorships[4].author.display_name	Henk Pieters
authorships[4].author_position	middle
authorships[4].raw_author_name	Henk Pieters
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5017786250
authorships[5].author.orcid
authorships[5].author.display_name	Nicolas Frans
authorships[5].author_position	middle
authorships[5].raw_author_name	Nicolas Frans
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5013545831
authorships[6].author.orcid	https://orcid.org/0000-0003-1616-5240
authorships[6].author.display_name	Edward Yi Chang
authorships[6].author_position	middle
authorships[6].raw_author_name	Edward Chang
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5103851023
authorships[7].author.orcid
authorships[7].author.display_name	Qingfeng Tao
authorships[7].author_position	middle
authorships[7].raw_author_name	Qingfeng Tao
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5000514821
authorships[8].author.orcid	https://orcid.org/0000-0003-4144-7688
authorships[8].author.display_name	Marc Vanhove
authorships[8].author_position	middle
authorships[8].raw_author_name	Marc Vanhove
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5103457270
authorships[9].author.orcid
authorships[9].author.display_name	Annabelle Lejeune
authorships[9].author_position	middle
authorships[9].raw_author_name	Annabelle Lejeune
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5073919603
authorships[10].author.orcid
authorships[10].author.display_name	Reinoud van Gool
authorships[10].author_position	middle
authorships[10].raw_author_name	Reinoud van Gool
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5083217155
authorships[11].author.orcid	https://orcid.org/0000-0001-9604-5948
authorships[11].author.display_name	Daniel J. Sexton
authorships[11].author_position	middle
authorships[11].raw_author_name	Daniel J. Sexton
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5080696697
authorships[12].author.orcid
authorships[12].author.display_name	Guannan Kuang
authorships[12].author_position	middle
authorships[12].raw_author_name	Guannan Kuang
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5105710753
authorships[13].author.orcid
authorships[13].author.display_name	Douglas Rank
authorships[13].author_position	middle
authorships[13].raw_author_name	Douglas Rank
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5109445583
authorships[14].author.orcid
authorships[14].author.display_name	Shannon Hogan
authorships[14].author_position	middle
authorships[14].raw_author_name	Shannon Hogan
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5066794581
authorships[15].author.orcid
authorships[15].author.display_name	Csaba Pazmany
authorships[15].author_position	middle
authorships[15].raw_author_name	Csaba Pazmany
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5110884034
authorships[16].author.orcid	https://orcid.org/0009-0002-8507-4086
authorships[16].author.display_name	Yu Lu
authorships[16].author_position	middle
authorships[16].raw_author_name	Yu Lu Ma
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5083248117
authorships[17].author.orcid
authorships[17].author.display_name	Sonia Schoonbroodt
authorships[17].author_position	middle
authorships[17].raw_author_name	Sonia Schoonbroodt
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5006543521
authorships[18].author.orcid	https://orcid.org/0000-0002-6090-0583
authorships[18].author.display_name	Andrew E. Nixon
authorships[18].author_position	middle
authorships[18].raw_author_name	Andrew E. Nixon
authorships[18].is_corresponding	False
authorships[19].author.id	https://openalex.org/A5007558447
authorships[19].author.orcid
authorships[19].author.display_name	Robert C. Ladner
authorships[19].author_position	middle
authorships[19].raw_author_name	Robert C. Ladner
authorships[19].is_corresponding	False
authorships[20].author.id	https://openalex.org/A5110535286
authorships[20].author.orcid
authorships[20].author.display_name	Rene Hoet
authorships[20].author_position	middle
authorships[20].raw_author_name	Rene Hoet
authorships[20].is_corresponding	False
authorships[21].author.id	https://openalex.org/A5042618416
authorships[21].author.orcid	https://orcid.org/0000-0002-7163-8226
authorships[21].author.display_name	Paula Henderikx
authorships[21].author_position	middle
authorships[21].raw_author_name	Paula Henderikx
authorships[21].is_corresponding	False
authorships[22].author.id	https://openalex.org/A5111599337
authorships[22].author.orcid
authorships[22].author.display_name	Chris TenHoor
authorships[22].author_position	middle
authorships[22].raw_author_name	Chris TenHoor
authorships[22].is_corresponding	False
authorships[23].author.id	https://openalex.org/A5051435795
authorships[23].author.orcid	https://orcid.org/0000-0001-5594-3899
authorships[23].author.display_name	Shafaat A. Rabbani
authorships[23].author_position	middle
authorships[23].raw_author_name	Shafaat A. Rabbani
authorships[23].is_corresponding	False
authorships[24].author.id	https://openalex.org/A5077793169
authorships[24].author.orcid
authorships[24].author.display_name	Maria Luisa Valentino
authorships[24].author_position	middle
authorships[24].raw_author_name	Maria Luisa Valentino
authorships[24].is_corresponding	False
authorships[25].author.id	https://openalex.org/A5071180052
authorships[25].author.orcid
authorships[25].author.display_name	Clive R. Wood
authorships[25].author_position	middle
authorships[25].raw_author_name	Clive R. Wood
authorships[25].is_corresponding	False
authorships[26].author.id	https://openalex.org/A5068642499
authorships[26].author.orcid
authorships[26].author.display_name	Daniel T. Dransfield
authorships[26].author_position	last
authorships[26].raw_author_name	Daniel T. Dransfield
authorships[26].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/0008-5472.c.6499896
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Data from Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10620
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.970300018787384
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1306
primary_topic.subfield.display_name	Cancer Research
primary_topic.display_name	Protease and Inhibitor Mechanisms
related_works	https://openalex.org/W2388520405, https://openalex.org/W1971898819, https://openalex.org/W2304095413, https://openalex.org/W2094856604, https://openalex.org/W622582005, https://openalex.org/W1936396226, https://openalex.org/W4241582355, https://openalex.org/W1156698136, https://openalex.org/W3015815503, https://openalex.org/W2139825188
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1158/0008-5472.c.6499896
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/0008-5472.c.6499896
primary_location.id	doi:10.1158/0008-5472.c.6499896
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/0008-5472.c.6499896
publication_date	2023-03-30
publication_year	2023
referenced_works_count	0
abstract_inverted_index.a	15, 24, 62, 109
abstract_inverted_index.To	48
abstract_inverted_index.an	7, 42
abstract_inverted_index.in	27
abstract_inverted_index.is	6
abstract_inverted_index.of	1, 44, 52, 92, 97, 108, 116
abstract_inverted_index.on	79
abstract_inverted_index.to	11, 22, 41, 54
abstract_inverted_index.we	59
abstract_inverted_index.Res	120
abstract_inverted_index.The	95
abstract_inverted_index.and	31, 57, 81, 86, 90, 100
abstract_inverted_index.for	113
abstract_inverted_index.has	19
abstract_inverted_index.the	50, 106, 114
abstract_inverted_index.been	20
abstract_inverted_index.play	23
abstract_inverted_index.role	26
abstract_inverted_index.used	60
abstract_inverted_index.zinc	17
abstract_inverted_index.(MMP)	5
abstract_inverted_index.fully	65
abstract_inverted_index.human	66
abstract_inverted_index.phage	72
abstract_inverted_index.shows	105
abstract_inverted_index.solid	117
abstract_inverted_index.tumor	28, 55, 80, 88
abstract_inverted_index.using	71
abstract_inverted_index.MMP-14	37, 53, 67, 111
abstract_inverted_index.cancer	12
abstract_inverted_index.cells,	83
abstract_inverted_index.growth	56
abstract_inverted_index.highly	63
abstract_inverted_index.matrix	3, 35
abstract_inverted_index.robust	101
abstract_inverted_index.slowed	87
abstract_inverted_index.Besides	33
abstract_inverted_index.DX-2400	75
abstract_inverted_index.MMP-14,	14
abstract_inverted_index.[Cancer	119
abstract_inverted_index.blocked	76
abstract_inverted_index.central	25
abstract_inverted_index.display	73
abstract_inverted_index.examine	49
abstract_inverted_index.growth,	29
abstract_inverted_index.leading	40
abstract_inverted_index.tumors.	118
abstract_inverted_index.DX-2400,	61
abstract_inverted_index.activity	104
abstract_inverted_index.antibody	69
abstract_inverted_index.approach	10
abstract_inverted_index.cleaving	34
abstract_inverted_index.lesions.	94
abstract_inverted_index.potency,	98
abstract_inverted_index.proMMP-2	39, 77
abstract_inverted_index.proposed	21
abstract_inverted_index.specific	2
abstract_inverted_index.therapy.	13
abstract_inverted_index.activates	38
abstract_inverted_index.activity.	47
abstract_inverted_index.formation	91
abstract_inverted_index.inhibited	84
abstract_inverted_index.inhibitor	112
abstract_inverted_index.invasion,	30
abstract_inverted_index.potential	107
abstract_inverted_index.proteins,	36
abstract_inverted_index.selective	64, 110
abstract_inverted_index.treatment	115
abstract_inverted_index.attractive	8
abstract_inverted_index.discovered	70
abstract_inverted_index.inhibitory	68
abstract_inverted_index.metastatic	93
abstract_inverted_index.processing	78
abstract_inverted_index.<i>in	102
abstract_inverted_index.combination	96
abstract_inverted_index.endothelial	82
abstract_inverted_index.progression	89
abstract_inverted_index.proteolytic	46
abstract_inverted_index.technology.	74
abstract_inverted_index.contribution	51
abstract_inverted_index.noncytotoxic	9
abstract_inverted_index.pericellular	45
abstract_inverted_index.selectivity,	99
abstract_inverted_index.amplification	43
abstract_inverted_index.angiogenesis,	58, 85
abstract_inverted_index.endopeptidase,	18
abstract_inverted_index.membrane-bound	16
abstract_inverted_index.vivo</i>	103
abstract_inverted_index.metalloproteinases	4
abstract_inverted_index.neovascularization.	32
abstract_inverted_index.<div>Abstract<p>Inhibition	0
abstract_inverted_index.2009;69(4):1517–26]</p></div>	121
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	27
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7099999785423279
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.55956119
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False